课题基金 / 基金详情

HCMV DNA REPLICATION GENES IDENTIFIED BY TRANSIENT ASSAY

HCMV DNA REPLICATION GENES IDENTIFIED BY TRANSIENT ASSAY
瞬时检测鉴定出 HCMV DNA 复制基因
批准号:
2672173
负责人:
DAVID G. ANDERS
金额:
$13.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-12-01 至 2000-05-31

项目摘要

项目成果

DAVID G. ANDERS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (HCMV) is a frequent opportunistic pathogen, causing extensive morbidity and mortality. It is the most common known congenital virus infection in the United States, sometimes with serious or fatal consequences. In immunocompromised individuals HCMV infection or reactivation can be fatal. HCMV is a particular problem in AIDS patients, and may be a cofactor for HIV pathogenesis. A better understanding of the molecular mechanisms of HCMV DNA replication and their regulation is needed to aid in developing effective antiviral strategies. Lytic-phase DNA replication requires both a cis-acting origin of DNA replication, oriLyt, and transacting factors such as the virus-specified DNA polymerase. Eleven distinct HCMV loci, plus oriLyt, were implicated in origin-mediated DNA replication by transient complementation experiments using subclones of the viral genome. In addition, the open reading frame UL59, which lies within oriLyt, might also be required. The specific aims of this proposal are: (i) to determine if UL59 is required to complement DNA synthesis; (ii) to establish whether some of the loci that are required in trans for transient complementation are needed solely to allow expression of essential replication proteins, or if all loci encode proteins that participate directly in initiating or performing DNA replication; and (iii) to overexpress, purify, and characterize candidate replication proteins UL84, UL36, UL37, UL37ex1, and IRS1/TRS1, and to prepare immunological and biochemical tools for detailed analysis of their possible roles in DNA synthesis. These experiments will focus especially Ion those proteins that most likely play a role in regulating and promoting initiation. The methods to be used include: (i) a transient complementation assay using heterologous promoter constructs designed to allow expression independent of HCMV-specified transactivators; (ii) prokaryotic and eukaryotic systems for protein overexpression; and (iii) standard biochemical techniques including electrophoresis and column and affinity chromatography to purify and characterize the protein factors. The long term goals are to contribute to a comprehensive understanding of the molecular mechanisms and biological strategies of HCMV DNA replication and to the development of an in vitro DNA replication system, and to aid development of novel antiviral agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A MOLECULAR BASIS FOR THE RHESUS CYTOMEGALOVIRUS MODEL
  • 批准号:
    6261428
  • 项目类别:
  • 资助金额:
    $12.44万
  • 财政年份:
    2001
  • 负责人:
    DAVID G. ANDERS
  • 依托单位:
A MOLECULAR BASIS FOR THE RHESUS CYTOMEGALOVIRUS MODEL
  • 批准号:
    6499488
  • 项目类别:
  • 资助金额:
    $12.53万
  • 财政年份:
    2001
  • 负责人:
    DAVID G. ANDERS
  • 依托单位:
HCMV DNA REPLICATION GENES IDENTIFIED BY TRANSIENT ASSAY
  • 批准号:
    2068417
  • 项目类别:
  • 资助金额:
    $11.29万
  • 财政年份:
    1992
  • 负责人:
    DAVID G. ANDERS
  • 依托单位:
HCMV DNA REPLICATION GENES IDENTIFIED BY TRANSIENT ASSAY
  • 批准号:
    2068419
  • 项目类别:
  • 资助金额:
    $12.53万
  • 财政年份:
    1992
  • 负责人:
    DAVID G. ANDERS
  • 依托单位:
海外基金